Jiri Dusek

Dr. Jiri Dusek

University of South Bohemia in České Budějovice, České Budějovice, Jihočeský Kraj, Czech Republic
+1
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
Jiri DusekJiri Dusek
Jiri Dusek
LNLenka Nedvědová
Lenka Nedvědová
OSOndrej Scheinost
Ondrej Scheinost
MHMilan Hanzl
Milan Hanzl
EKEva Kantorova
Eva Kantorova
Jan VoracekJan Voracek
Jan Voracek
It has been hypothesized that fetal prematurity or Intrauterine Growth Restriction (IUGR) could be related to the presence of factor V of Leiden mutation. This mutation is associated with a higher incidence of pregnancy difficulties that can result in preterm birth. The frequency of Leiden mutation was investigated in the group of newborns with a low birth weight below 1500 g over a six-year period from 2015 to 2020. During this period, 339 newborns were tested, of which 42 newborns with V Leiden mutation (12.4%) were detected. The average of its occurrence frequency in the Czech population was determined as 5.0% based on published studies. In our research, the occurrence of the V Leiden mutation was found significantly higher in newborns under 1500 g. At the same time, we did not demonstrate an increased frequency of births at lower gestational weeks, lower birth weight, or an association with sex in newborns with a positive diagnosis of the Leiden V factor.

29 October 2022 in Children
Verified
Journal Article
Open access
PDF file
Jiri DusekJiri Dusek
Jiri Dusek
ESEliska Simkova
Eliska Simkova
EFEva Fendrstatova
Eva Fendrstatova
RSRadim J. Sram
Radim J. Sram
HKHana Kotouckova
Hana Kotouckova
Jan VoracekJan Voracek
Jan Voracek
Background: The aim of our study was to compare the analgesic/sedative effects of various fundus-related procedural pain management strategies on the risk of retinopathy in premature infants. Method: This was a prospective comparative study involving a total of 94 neonates randomized to three groups meeting the criteria for at-risk neonates. Ophthalmologic screening was performed to evaluate the outcome of three procedural pain management strategies. The intensity of pain over time during and after the screening examination was evaluated. At the same time, we also looked at the occurrence of vegetative symptoms and their influence by the chosen medication. Pain response was observed in all 94 neonates enrolled in the study. In group A, no pain treatment was given. Group B had a local anesthetic oxybuprocaine hydrochloride 0.4% introduced into both eyes immediately prior to the examination. Group C received oral clonidine. The study was conducted as a pilot project and aimed to clarify the problem so that a project with a higher proband representation could take place in the future. Consequently, we performed quantitative analysis of complete pain and vegetative functions, followed by a qualitative analysis of their internal components. Results: In our study, we identified the most considerable effects for all three groups, including NIPS (Neonatal Infant Pain Scale) responses immediately during and after the examination. The influence of vegetative functions is of a longer-term nature and increased values can be clearly demonstrated even six hours after the examination. Conclusion: The current results identify and quantify differences among all three methods of pain treatment on the level of single variables. Their internal structures, however, can be analysed only qualitatively because of the small size of the analysed sample.

23 May 2026 in Cureus
Verified
Journal Article
Open access
PDF file
Jiri DusekJiri Dusek
Jiri Dusek
LNLenka Nedvedova
Lenka Nedvedova
EREva Rysava
Eva Rysava
JBJosef Bartl
Josef Bartl
PPPetra Pokorna
Petra Pokorna
KSKaterina Slaba
Katerina Slaba
Adenylosuccinate lyase deficiency (ADSLD) is an ultra-rare autosomal recessive disorder of purine metabolism. The most severe neonatal phenotype presents with profound encephalopathy from birth, hypotonia, respiratory insufficiency, and early seizures. A preterm infant was delivered at 34+0 weeks with antenatal progressive microcephaly and mild polyhydramnios. At birth, the neonate exhibited absent spontaneous respiration and marked hypotonia, necessitating ventilation and intubation. Respiratory distress syndrome (RDS) was managed with surfactant, but two extubation attempts with non-invasive continuous positive airway pressure/biphasic positive airway pressure (nCPAP/DuoPAP) were unsuccessful. Neurologically, the infant demonstrated profound central hypotonia, stimulus-induced myoclonus, and a burst-suppression pattern on amplitude-integrated electroencephalography (aEEG). Antiseizure therapy with phenobarbital and levetiracetam was initiated. Brain magnetic resonance imaging (MRI) revealed microcephaly with simplified gyrification, bilateral intraventricular hemorrhage (IVH) with additional posterior fossa hemorrhage, delayed myelination, and evolving post-hemorrhagic hydrocephalus. Targeted biochemical testing identified markedly elevated succinylpurines (succinyladenosine (S-Ado) and SAICA-riboside (SAICAr)) in urine and serum. Rapid whole-genome sequencing (WGS) confirmed autosomal recessive ADSLD. In the absence of disease-modifying therapy and given the extremely poor prognosis, care was transitioned to comfort-focused palliation. ADSLD should be considered in neonates presenting with severe microcephaly, profound hypotonia, and early epileptic encephalopathy. Rapid genomic testing, when available and clinically appropriate, may enable timely etiologic diagnosis, supporting prognostication and shared decision-making.